Zobrazeno 1 - 1
of 1
pro vyhledávání: '"M Urretavizkaya Anton"'
Autor:
G Lizeaga Cundin, J Landa Alberdi, A Lizardi Mutuberria, MP Bachiller Cacho, MJ Garcia de Andoin Barandiaran, L Leunda Eizmendi, MA Aranguren Redondo, A Zurutuza Lopez, M Urretavizkaya Anton, Dan Garcia, T Gonzalez Fernandez
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background In the pivotal authorisation trial of carfilzomib, patients with severe cardiovascular abnormalities (NYHA III or IV), clinically significant and uncontrolled, were not included. Purpose The aim of this study was to analyse the cardiovascu